Lumida
/OSCR
⌘K
Oscar Health Inc

Oscar Health Inc

OSCR
$29.10USD↑+0.83%+0.24 today

MARKET CAP

8.8B

P/E (TTM)

—

FWD P/E

26.7x

DAY RANGE

$28 – $29

52W RANGE

$11
$33

AI Summary

Stalk
StalkMedium

OSCR remains in a clear Stage 2 advancing uptrend with both long‐ and medium‐term structures rising, but the recent blow‐off top and overbought extension above the 9/21 EMAs warrant patience. Medium‐term bias is bullish under Stage 2, yet short‐term execution is deferred until shallow pullbacks into the rising 9/21 EMA support zone, where a favorable entry asymmetry may develop.

  • ↑Revenue surged to $4.6B in Q1 (+53% YoY); members hit 3.2M (+56% YoY).
  • ↑SG&A expense ratio reached a historic low of 15.2% after AI integration.
  • ↓MLR rose to 91.1%, highlighting higher claims and risk costs.
Full analysis →

The case for & against

Bull & Bear analysis

Bullish

Oscar Health, Inc. (NYSE: OSCR) is a technology-driven health insurance provider focusing on the individual health insurance market, particularly through the Affordable Care Act (ACA) marketplace. The company uses advanced technology to deliver affordable healthcare solutions, making it a rapidly growing player in the healthcare technology sector. Oscar is focused on enhancing consumer choice and value, positioning itself as a disruptor in the traditional insurance landscape.

Bull says

  • ↑Revenue surged to $4.6B in Q1 (+53% YoY); members hit 3.2M (+56% YoY).
  • ↑SG&A expense ratio reached a historic low of 15.2% after AI integration.
  • ↑Net income $679M ($2.07/sh), highest quarterly profit in company history.
  • ↑Analyst upgrades (e.g., Barclays OW, $35 PT) signal margin recovery optimism.
  • ↑Cash and investments of $8.1B support growth and liquidity needs.
  • ↑Positive growth momentum with strong earnings revisions and undervalued book-to-price.

Bear says

  • ↓MLR rose to 91.1%, highlighting higher claims and risk costs.
  • ↓Expiration of enhanced premium tax credits may trigger member churn.
  • ↓Negative earnings yield and low profitability raise return concerns.
  • ↓SG&A ratio expected to tick up as membership scales, pressuring margins.
  • ↓High volatility and balance-sheet risks could deter institutional investors.
  • ↓Regulatory shifts and fierce insurer competition pose long-term hurdles.

Investment themes with OSCR

L&H Insurance↑ +0.32%

PGR · TRV · ALL

Earnings Call · Q1 2026 · Mgmt. Guidance

Updated 05-10-2026bullish

Transcript signals

Bull points

  • OSCAR Health announced strong first quarter 2026 results with year-over-year improvement across all core metrics.
  • Oscar reported revenue of $4.6 billion, an increase of 53% year-over-year.
  • We delivered $704 million in earnings from operations, an increase of nearly two and a half times over the same period last year.

Bear points

  • weekly's new report shows market contraction is tracking in line to favorable to our 20 to 30 percent estimate.
  • The small group market is contracting, and consumers are rejecting the legacy model.
  • we continue to expect gradual churn throughout the balance of the year consistent with pre-ARPA levels.
Read full transcript analysis ›